Document Detail


Effect of perioperative administration of dexketoprofen on opioid requirements and inflammatory response following elective hip arthroplasty.
MedLine Citation:
PMID:  12066728     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In this double-blind, randomized, placebo-controlled trial, the safety and analgesic efficacy of perioperative dexketoprofen were evaluated. METHODS: Thirty ASA I or II patients undergoing elective hip arthroplasty were randomized to one of two groups. One group (D) received dexketoprofen 25 mg tds for 24 h before and 48 h after surgery; the second group (P) received placebo tablets at equivalent times. Hyperbaric 0.5% bupivacaine (17.5 mg if greater than 70 kg and 15 mg if less than 70 kg) and preservative-free morphine (0.6 mg) were administered intrathecally. Postoperatively, PCA was provided (bolus morphine sulphate 1 mg; lockout 5 min; no continuous infusion). RESULTS: The two groups were similar in terms of age, gender, weight, height, ASA class, duration of operation, and level of sensory block on arrival to the recovery room. Groups were also similar in terms of blood loss, transfusion requirements, ventilatory frequency, and haemodynamic variables. According to visual analogue pain scores patients in group D experienced less pain at 15 h (P=0.02) postoperatively. Cumulative morphine consumption was also less in group D compared with group P at 6 (0.06 (0.2) vs 0.85 (1.4) mg, P=0.04) and 48 h postoperatively (10.1 (8) vs 26.2 (20) mg, P<0.01). Plasma interleukin 6 concentrations increased postoperatively to a significantly lesser extent in group D than in group P (P=0.02). Nausea and vomiting were less (P<0.01) in group D compared with group P at 18 h postoperatively. Sedation scores were less (P=0.03) in group D. CONCLUSIONS: Perioperative administration of dexketoprofen 25 mg 8 hourly markedly improves analgesia and decreases opioid requirements (and associated adverse effects) following hip arthroplasty. It appears that this regimen decreases the postoperative pro-inflammatory response.
Authors:
G Iohom; M Walsh; G Higgins; G Shorten
Related Documents :
15800758 - Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosph...
19776408 - A double-blind, delayed-start trial of rasagiline in parkinson's disease.
10819278 - Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip re...
9285918 - Absence of a synergistic effect between fumonisin b1 and n-nitrosomethylbenzylamine in ...
11197968 - Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after expo...
1174718 - Lymphocytosis induced by polymethacrylic acid. dose-effect and toxicity.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of anaesthesia     Volume:  88     ISSN:  0007-0912     ISO Abbreviation:  Br J Anaesth     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-06-17     Completed Date:  2002-06-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372541     Medline TA:  Br J Anaesth     Country:  England    
Other Details:
Languages:  eng     Pagination:  520-6     Citation Subset:  IM    
Affiliation:
Department of Anaesthesia and Intensive Care Medicine, Cork University Hospital and National University of Ireland, Republic of Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Analgesics, Opioid / administration & dosage*
Anesthesia, Spinal
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Arthroplasty, Replacement, Hip*
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Hemodynamics / drug effects
Humans
Inflammation / prevention & control*
Ketoprofen / analogs & derivatives*,  therapeutic use*
Male
Middle Aged
Pain, Postoperative / prevention & control*
Perioperative Care / methods
Prospective Studies
Tromethamine / analogs & derivatives*,  therapeutic use*
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/dexketoprofen trometamol; 22071-15-4/Ketoprofen; 77-86-1/Tromethamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of mepivacaine and lidocaine for intravenous regional anaesthesia: pharmacokinetic study ...
Next Document:  Randomized crossover comparison of the proseal with the classic laryngeal mask airway in unparalysed...